I-SPY-Phase I/Ib (PRE-I-SPY Program) PRE-Investigation of serial studies to predict your therapeutic response with imaging and moLecular analysis: A Phase I/Ib platform trial

Disease:

HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer, Metastatic, HER2-positive Metastatic Breast Cancer, HER2 Mutation-Related Tumors, HER-2 Protein Overexpression, HER2-negative Breast Cancer, Triple Negative Breast Cancer, HR Positive, Hormone Receptor-positive Breast Cancer, Estrogen Receptor Positive Tumor, Progesterone Receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma, Solid Tumor, Solid Tumor, Adult, Solid Carcinoma, HER2 Low Breast Cancer, HER2 Low Breast Carcinoma, ER Positive Breast Cancer, PR-positive Breast Cancer

Study phase:

Phase I

Physician name:

Paula Pohlmann

Department:

Investigational Cancer Therapeutics

For general questions about clinical trials:

1-855-798-1207